$3.75
1.90% yesterday
Nasdaq, Jun 06, 10:04 pm CET
ISIN
US09075F1075
Symbol
BNGO
Sector
Industry

BioNano Genomics, Inc. Stock price

$3.75
+0.05 1.35% 1M
-10.27 73.26% 6M
-13.55 78.33% YTD
-49.63 92.97% 1Y
-321.21 98.85% 5Y
-4,190.25 99.91% 10Y
-4,190.25 99.91% 20Y
Nasdaq, Closing price Fri, Jun 06 2025
+0.07 1.90%
ISIN
US09075F1075
Symbol
BNGO
Sector
Industry

Key metrics

Market capitalization $12.62m
Enterprise Value $-1.83m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 0.04
EV/Sales (TTM) EV/Sales -0.06
P/S ratio (TTM) P/S ratio 0.44
P/B ratio (TTM) P/B ratio 0.24
Revenue growth (TTM) Revenue growth -24.05%
Revenue (TTM) Revenue $28.46m
EBIT (operating result TTM) EBIT $-58.70m
Free Cash Flow (TTM) Free Cash Flow $-43.63m
Cash position $18.23m
EPS (TTM) EPS $-31.06
P/E forward negative
P/S forward 0.41
EV/Sales forward negative
Short interest 17.08%
Show more

Is BioNano Genomics, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,823 stocks worldwide.

BioNano Genomics, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

4 Analysts have issued a BioNano Genomics, Inc. forecast:

2x Buy
50%
2x Hold
50%

Analyst Opinions

4 Analysts have issued a BioNano Genomics, Inc. forecast:

Buy
50%
Hold
50%

Financial data from BioNano Genomics, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
28 28
24% 24%
100%
- Direct Costs 28 28
3% 3%
98%
0.49 0.49
95% 95%
2%
- Selling and Administrative Expenses 42 42
52% 52%
147%
- Research and Development Expense 17 17
65% 65%
61%
-45 -45
60% 60%
-158%
- Depreciation and Amortization 14 14
1% 1%
48%
EBIT (Operating Income) EBIT -59 -59
54% 54%
-206%
Net Profit -84 -84
63% 63%
-294%

In millions USD.

Don't miss a Thing! We will send you all news about BioNano Genomics, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

BioNano Genomics, Inc. Stock News

Neutral
GlobeNewsWire
19 days ago
SAN DIEGO, May 19, 2025 (GLOBE NEWSWIRE) -- Bionano Laboratories, a wholly-owned subsidiary of Bionano Genomics, Inc. (Nasdaq: BNGO) that offers CLIA-certified laboratory developed tests (LDTs) based on optical genome mapping (OGM), today announced that the editorial panel of the American Medical Association (AMA) established a new Category I Current Procedural Terminology (CPT®) code for the u...
Neutral
Seeking Alpha
23 days ago
Bionano Genomics, Inc. (NASDAQ:BNGO ) Q1 2025 Earnings Conference Call May 14, 2025 4:30 PM ET Company Participants David Holmes - IR Erik Holmlin - CEO and Principal Financial Officer Conference Call Participants Sung Ji Nam - Scotiabank Vivian Alhorn - BTIG Joanne Lee - Maxim Group Operator Good day, and welcome to the Bionano First Quarter 2025 Earnings Conference Call. Today's conference is...
Neutral
GlobeNewsWire
23 days ago
SAN DIEGO, May 14, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the first quarter ended March 31, 2025. “The first quarter of 2025 represents the first full quarter of execution after shifting strategy towards a focus on our base of routine users of optical genome mapping (OGM) and VIA™ software as the primary drivers of our revenue and gro...
More BioNano Genomics, Inc. News

Company Profile

BioNano Genomics, Inc. is a life sciences instrumentation company, which focuses on genome analysis space. The firm engages in the development and marketing of Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline cytogenetics. The company was founded by Han Cao in October 2003 and is headquartered in San Diego, CA.

Head office United States
CEO Robert Holmlin
Employees 99
Founded 2003
Website bionano.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today